Hyaline-Vascular Type Castleman's Disease, Sarcoidosis, and Crohns Disease.

Indian J Hematol Blood Transfus

Department of Gastroenterology and Hepatology, University of Texas Southwestern Medical Center, Seay Biomedical Building, 2201 Inwood Road, Dallas, TX 75390-8562 USA ; Department of Hematology Oncology, University of Texas Southwestern Medical Center, Dallas, TX USA.

Published: June 2016

Sarcoidosis and Crohns disease have been associated with increased long term risk of lymphoproliferative disorders, including lymphomas. Newly developed lymphadenopathy in a patient with these disorders should prompt pathological evaluation. Castleman's disease is a lymphoproliferative disorder characterized by enlarged hyperplastic lymph nodes with regressed follicles surrounded by expanded mantle zones of small lymphocytes, and interfollicular vascular proliferation in the hyaline-vascular type. Similar to sarcoidosis and Crohns disease, its etiology is incompletely understood, although immune dysregulation, genetic factors and infectious and environmental factors are thought to play a role in all three diseases. Interleukin-6 is a possible pathological common factor between these three disease processed. Unicentric, hyaline-vascular type Castleman's disease can be treated successfully with complete surgical resection. We report a patient with long history of sarcoidosis and Crohns disease with newly developed lymphadenopathy which was found to be due to Castleman's disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925517PMC
http://dx.doi.org/10.1007/s12288-015-0580-8DOI Listing

Publication Analysis

Top Keywords

castleman's disease
16
sarcoidosis crohns
16
crohns disease
16
hyaline-vascular type
12
disease
9
type castleman's
8
disease sarcoidosis
8
newly developed
8
developed lymphadenopathy
8
castleman's
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!